Valuation: Amarin Corporation plc

Market Cap 28Cr 24Cr 23Cr 21Cr 39Cr 2.67TCr 40Cr 276.52Cr 107.1Cr 1.37TCr 104.69Cr 102.42Cr 4.39TCr P/E 2026 *
-189x
P/E 2027 * -220x
Enterprise Value 12Cr 10Cr 9.66Cr 8.8Cr 16Cr 1.12TCr 17Cr 115.58Cr 45Cr 570.66Cr 44Cr 43Cr 1.83TCr EV / Sales 2026 *
0.66x
EV / Sales 2027 * 0.59x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day-1.71%
1 week-3.15%
Current month-4.90%
1 month-8.17%
3 months-17.03%
6 months-10.02%
Current year-5.41%
1 week 13
Extreme 13
13.9
1 month 13
Extreme 13
14.9
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
107.2
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
01/08/26 Exercice

Chief Financial Officer

781 0.0002%
01/07/26 Exercice

Chief Operating Officer

9,302 0.0022%
01/07/26 Exercice

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-3.15%-17.50%-21.89% 28Cr
-3.30%+1.50%+57.79%+99.14% 7.23TCr
+1.25%-3.01%+37.83%+87.66% 6.02TCr
+2.12%+5.26%+35.69%+23.40% 2.77TCr
-3.06%-1.81%-14.01%+357.24% 2.57TCr
-0.75%+2.56%+0.45%-3.28% 2.47TCr
+0.40%+0.75%+23.72%-11.33% 2.07TCr
-1.70%-2.12%+150.24%+326.97% 1.51TCr
+0.36%-0.34%+48.98%+167.40% 1.44TCr
+0.21%+1.17%-3.95%+512.06% 1.42TCr
Average -0.62%+0.08%+31.92%+153.74% 2.75TCr
Weighted average by Cap. -0.77%+0.31%+38.10%+132.84%

Financials

2026 *2027 *
Net sales 18Cr 16Cr 15Cr 13Cr 25Cr 1.7TCr 25Cr 175.98Cr 68Cr 868.86Cr 67Cr 65Cr 2.79TCr 18Cr 16Cr 15Cr 13Cr 25Cr 1.69TCr 25Cr 175.38Cr 68Cr 865.89Cr 66Cr 65Cr 2.78TCr
Net income -2.66Cr -2.34Cr -2.21Cr -2.01Cr -3.76Cr -255.17Cr -3.79Cr -26Cr -10Cr -130.36Cr -10Cr -9.78Cr -418.97Cr -1.83Cr -1.61Cr -1.52Cr -1.38Cr -2.59Cr -175.58Cr -2.61Cr -18Cr -7.04Cr -90Cr -6.88Cr -6.73Cr -288.28Cr
Net Debt -16Cr -14Cr -13Cr -12Cr -23Cr -1.56TCr -23Cr -160.94Cr -62Cr -794.59Cr -61Cr -60Cr -2.55TCr -17Cr -15Cr -14Cr -13Cr -25Cr -1.68TCr -25Cr -173.44Cr -67Cr -856.31Cr -66Cr -64Cr -2.75TCr
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
25/26/25 $13.20 -1.71% 1,27,281
24/26/24 $13.43 -2.11% 47,935
23/26/23 $13.72 -0.22% 59,839
22/26/22 $13.75 +2.00% 59,062
21/26/21 $13.48 -1.10% 38,789
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
13.20USD
Average target price
12.50USD
Spread / Average Target
-5.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock